Sro77, alongside its paralog Sro7, shares homology with the Drosophila tumor suppressor lethal giant larvae (Lgl) . Key roles include:
Exocytosis regulation: Sro77 binds Sec9p (a plasma membrane SNARE protein) to facilitate vesicle docking and fusion during secretion .
Cell polarity and integrity: Double deletion of SRO7/SRO77 disrupts actin cytoskeleton organization, leading to defects like multi-budding, cell lysis, and irregular chitin distribution .
Rho1-TOR1 pathway modulation: Sro77 acts upstream of Rho1 GTPase, which regulates TOR1 activity to control cell growth and stress responses .
While no commercial SRO77 antibody is explicitly detailed in the provided sources, studies infer its use for:
Protein localization: Detecting Sro77p expression in yeast colonies via immunofluorescence or Western blotting.
Functional assays: Validating genetic interactions (e.g., rescuing sro7Δ/sro77Δ phenotypes by RHO1 overexpression) .
Quantitative analysis: Measuring mRNA/protein levels under stress conditions (e.g., NaCl exposure) .
| Parameter | sro7Δ/sro77Δ Phenotype | sro7Δ/sro77Δ + RHO1 |
|---|---|---|
| Colony morphology | Small, smooth surface | WT-like morphology |
| Chitin localization | Diffuse | Bud scar-focused |
| TOR1 mRNA levels | Elevated | Normalized to WT |
Rho1 activation: Sro77 promotes GTP-bound Rho1, which stabilizes TOR1 signaling. Deletion of TOR1 restores normal growth in sro7Δ/sro77Δ .
Evolutionary conservation: Sro77’s homology to Lgl suggests conserved roles in suppressing uncontrolled cell proliferation, analogous to tumor suppression in higher eukaryotes .
Antibody validation: Specificity for Sro77 should be confirmed via knockout strains or epitope tagging (e.g., HA/FLAG) .
Experimental models: Phenotypes are more pronounced in colonies (solid media) than liquid cultures, highlighting the need for context-specific analyses .
Therapeutic potential: While SRO77 itself is not a therapeutic target, its regulatory pathways (e.g., Rho1-TOR1) may inform antifungal drug development.
Antibody engineering: Improved affinity/specificity could enable single-cell resolution studies of exocytosis dynamics.
KEGG: sce:YBL106C
STRING: 4932.YBL106C
SRO77 is a gene in Saccharomyces cerevisiae (baker's yeast) that functions as a homologue of the Drosophila tumor suppressor lethal giant larvae (Lgl). Along with its paralog SRO7, SRO77 belongs to a conserved family of proteins involved in regulating cell polarity across eukaryotes. The evolutionary conservation of this gene family from yeast to fruit flies and mammals suggests fundamental roles in cellular organization and growth regulation. SRO7 and SRO77 were initially identified as high-copy suppressors of Rho3 mutants, highlighting their connection to Rho GTPase signaling pathways .
SRO77, together with SRO7, plays important roles in:
Exocytosis regulation: Both proteins participate in the late stages of exocytosis.
Cell polarity maintenance: SRO77 helps establish and maintain asymmetric cell growth.
Cell wall integrity (CWI): SRO77 contributes to proper cell wall formation and maintenance.
Colony development: Proper SRO77 function is necessary for normal yeast colony morphology and structure.
When both SRO7 and SRO77 are deleted (sro7Δ/sro77Δ double deletion), cells exhibit multiple defects including abnormal budding patterns, multiple nuclei, cell lysis, and colony growth abnormalities .
SRO77 functions as an upstream regulator of Rho1 activation. In sro7Δ/sro77Δ double deletion mutants, the level of GTP-bound (active) Rho1 is significantly reduced, while total Rho1 protein levels remain unchanged. This indicates that SRO77 specifically impacts Rho1 activation rather than Rho1 expression. The evidence for this relationship includes:
Overexpression of RHO1 fully rescues sro7Δ/sro77Δ phenotypes
Pull-down assays show reduced Rho1-GTP levels in sro7Δ/sro77Δ mutants
Overexpression of ROM2 (a guanine nucleotide-exchange factor that activates Rho1) partially restores Rho1-GTP levels and rescues growth defects in sro7Δ/sro77Δ mutants
SRO77 indirectly regulates TOR (Target of Rapamycin) signaling through Rho1. In sro7Δ/sro77Δ mutants:
TOR1 mRNA levels are significantly elevated
Overexpression of RHO1 reduces TOR1 expression to wild-type levels
The mutants show increased sensitivity to rapamycin (a TOR inhibitor)
Deletion of TOR1 in the sro7Δ/sro77Δ background (creating a sro7Δ/sro77Δ/tor1Δ triple mutant) recovers normal growth and colony morphology
These observations establish a regulatory pathway where SRO77 promotes Rho1 activation, which in turn negatively regulates TOR1 expression. When SRO77 is absent, reduced Rho1 activity leads to TOR1 upregulation and consequent growth abnormalities .
Double deletion of SRO7 and SRO77 results in distinct colony morphology abnormalities:
Significantly smaller colony size compared to wild-type
Rounder colonies with smoother surfaces
Defective colony differentiation
Abnormal internal colony structure with numerous dead cells, particularly near the middle of the colony
These morphological changes are consistent with defects in polarized growth and exocytosis. The presence of dead cells within the colony may represent a failure in nutrient distribution or could be related to the observed cell wall integrity defects .
Transmission electron microscopy (TEM) analysis of sro7Δ/sro77Δ cells reveals multiple cellular defects:
Multiple budding: Cells often display more than one bud, indicating defects in cell polarity regulation
Multiple nuclei: Individual cells may contain several nuclei, suggesting cytokinesis or nuclear division abnormalities
Cell lysis: Many cells exhibit membrane rupture and cytoplasmic leakage
Abnormal chitin distribution: Instead of being concentrated at bud scars (as in wild-type), chitin is dispersed throughout the cell wall
Thickened, irregular cell walls between mother and daughter cells
These phenotypes are more pronounced in cells from colonies grown on solid media than in cells grown in liquid culture, suggesting that the colony environment exacerbates these defects .
Several genetic approaches have proven valuable for investigating SRO77 function:
Gene deletion studies: Creating single (sro77Δ) and double (sro7Δ/sro77Δ) deletion mutants to assess functional redundancy
Overexpression studies: Introducing high-copy plasmids expressing SRO77 to rescue mutant phenotypes or identify genetic interactions
Suppressor screens: Identifying genes that, when overexpressed, can rescue sro7Δ/sro77Δ phenotypes (e.g., RHO1, ROM2)
Triple deletion analysis: Creating triple mutants (e.g., sro7Δ/sro77Δ/tor1Δ) to determine pathway relationships
Temperature sensitivity tests: Assessing growth at different temperatures (particularly cold sensitivity at 24°C)
These approaches have revealed functional relationships between SRO77 and other regulatory pathways, particularly those involving Rho1 GTPase and TOR signaling .
Multiple microscopy techniques have been employed to characterize SRO77-related phenotypes:
Transmission Electron Microscopy (TEM):
Particularly valuable for examining internal cellular structures
In situ fixation and processing enables direct observation of cell lysis processes
Reveals detailed abnormalities such as multiple nuclei, cell wall thickening, and membrane integrity defects
Fluorescence Microscopy:
Fluorescent Brightener 28 staining for chitin visualization
Reveals abnormal chitin distribution in sro7Δ/sro77Δ mutants
Colony Morphology Analysis:
SRO77 maintains cell wall integrity through several mechanisms:
Regulation of Rho1 activity: Rho1 is a central regulator of the Cell Wall Integrity (CWI) pathway
Proper chitin localization: SRO77 ensures that chitin is concentrated at bud scars rather than dispersed throughout the cell wall
Control of exocytosis: By regulating secretion, SRO77 ensures proper delivery of cell wall components to the growing bud
Prevention of cell lysis: TEM analysis of sro7Δ/sro77Δ mutants shows frequent cell lysis, directly demonstrating wall integrity defects
The observation that RHO1 overexpression rescues both morphological abnormalities and chitin localization defects in sro7Δ/sro77Δ mutants further supports the model that SRO77 acts through Rho1 to maintain cell wall integrity .
SRO77 plays a critical role in establishing and maintaining polarized cell growth:
Bud site selection: SRO77 helps determine the location of new buds
Polarized secretion: SRO77 directs secretory vesicles to growing buds
Cytoskeletal organization: Through Rho1 regulation, SRO77 affects actin cytoskeleton arrangements
Asymmetric cell division: Proper SRO77 function prevents multiple budding phenotypes
The involvement of SRO77 in polarized growth explains why sro7Δ/sro77Δ mutants exhibit multiple budding and defective colony morphology. These functions parallel the role of Lgl (the Drosophila homolog) in epithelial cell polarity, suggesting evolutionary conservation of this mechanism .
The homology between yeast SRO77 and the Drosophila tumor suppressor Lgl provides valuable insights for cancer research:
Conserved regulation of cell polarity: Both proteins control asymmetric cell growth
Growth suppression mechanisms: SRO77 negatively regulates TOR1 via Rho1, potentially similar to how mammalian Lgl homologs may suppress growth
Pathway conservation: The Rho1-TOR pathway regulated by SRO77 has parallels in mammalian cells, where Rho GTPases and mTOR signaling are implicated in cancer
Colony growth control: The ability of SRO77 to regulate yeast colony development may parallel tissue organization roles of Lgl in multicellular organisms
These parallels suggest that understanding SRO77 function in yeast could illuminate molecular mechanisms of tumor suppression in higher eukaryotes. The finding that SRO77 represses cell growth by regulating the TOR1 pathway via Rho1 may have particular relevance to understanding how Lgl-family proteins suppress tumorigenesis .
SRO7 and SRO77 display both redundant and distinct functions:
Redundancy: Single deletion of either gene produces minimal phenotypes, while double deletion causes severe defects
Cold sensitivity: Double deletion mutants grow poorly at 24°C but relatively normally at 30-37°C
Complementation: Overexpression of either gene can rescue the double deletion phenotype
Evolutionary conservation: Both are homologs of Drosophila Lgl, suggesting important conserved functions
Exocytosis: Both proteins function in late stages of exocytosis
The functional overlap between these paralogs likely reflects gene duplication and subsequent divergence, a common evolutionary pattern in S. cerevisiae. While they share core functions, subtle differences in their regulation or interaction partners may exist that aren't fully characterized in the current literature .
Several complementary techniques can assess Rho1 activation status:
| Technique | Application | Advantages | Limitations |
|---|---|---|---|
| Pull-down assays | Measure GTP-bound Rho1 levels | Directly quantifies active Rho1 | Requires specialized reagents |
| RT-PCR | Measure RHO1 mRNA levels | Assesses transcriptional regulation | Doesn't reflect protein activity |
| Western blotting | Measure total Rho1 protein | Quantifies protein abundance | Doesn't distinguish active/inactive forms |
| Genetic suppression | Test RHO1 overexpression effects | Provides functional evidence | Indirect measure of activation |
| ROM2/TUS1 overexpression | Activate Rho1 through GEFs | Tests pathway-specific activation | May have off-target effects |
In studying SRO77, researchers have employed these approaches to demonstrate that SRO77 affects Rho1-GTP levels without altering total Rho1 protein or mRNA expression .
Distinguishing direct versus indirect effects of SRO77 requires multiple lines of evidence:
Biochemical interaction studies: To determine if SRO77 physically interacts with putative targets
Epistasis analysis: Creating double and triple mutants to establish pathway relationships
Time-course experiments: To determine the temporal sequence of cellular responses
Domain mapping: Identifying specific protein domains required for different functions
Comparative analysis: Examining effects across different genetic backgrounds and conditions
For example, researchers established that SRO77 regulation of TOR1 is indirect (via Rho1) by demonstrating that RHO1 overexpression normalized TOR1 expression in sro7Δ/sro77Δ mutants. Similarly, the finding that tor1Δ rescues sro7Δ/sro77Δ phenotypes places TOR1 downstream of SRO77 in the signaling pathway .
Several promising research directions emerge from current understanding of SRO77:
Mechanistic studies: Further elucidating how SRO77 activates Rho1
Structural biology: Determining the three-dimensional structure of SRO77 and its interactions
Pathway mapping: Identifying additional components of the SRO77-Rho1-TOR pathway
Evolutionary comparisons: Deeper investigation of functional parallels with Lgl in higher eukaryotes
Cancer connections: Exploring whether human Lgl proteins regulate mTOR signaling similarly to how SRO77 regulates TOR1
Systems biology: Integrating SRO77 function into broader cellular networks
The discovery that SRO77 regulates cell proliferation via the Rho1-Tor1 pathway provides a foundation for understanding how similar mechanisms might function in cancer suppression, making comparative studies between yeast and mammalian systems particularly valuable .
Several methodological advances could significantly enhance SRO77 research:
Live-cell imaging: Real-time visualization of SRO77 localization and dynamics
Proximity labeling: Identifying proteins that interact transiently with SRO77
Single-cell analysis: Characterizing cell-to-cell variation in SRO77 activity within colonies
Computational modeling: Simulating SRO77-regulated pathways to generate testable predictions
Advanced genetic engineering: Creating subtle mutations to pinpoint specific functional domains